- Novartis leprosy medicine donation program with WHO extended to 2025
- Program has already treated over 7 million patients since 2000
- New evidence from contact tracing and preventive treatment program shows route to accelerate elimination
Basel, January 29, 2021 — A renewed partnership agreement signed by Novartis and the World Health Organization (WHO) will drive the global push towards making leprosy history. The five-year extension of the partnership – which was first signed in 2000 …